Beacon Therapeutics Launches with £96 Million ($120 million) to Develop a New Generation of Gene Therapies for Retinal Diseases Resulting in Blindness

London and Oxford, UK, June 12 (Korea Bizwire) – Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading ophthalmic gene therapy company with a purpose to restore and improve the vision of patients with retinal diseases, launches today and will develop a new generation of gene therapies to treat a range of rare and [...]